Curacle Co., Ltd. is engaged in the business of research and experimental development on medical sciences and pharmacy. It develops drugs for diabetes and stroke. The company was founded by Yeong-Geun, Kwon on May 12, 2016 and is headquartered in Seongnam-si, South Korea.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company